SV

Srikant Viswanadha

RA Rhizen Pharmaceuticals Ag: 8 patents #2 of 12Top 20%
IP Incozen Therapeutics Pvt.: 1 patents #2 of 5Top 40%
Overall (2017): #10,528 of 506,227Top 3%
8
Patents 2017

Issued Patents 2017

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDate
9815831 3,5-disubstituted-3H-imidazo[4,5-B]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of c-Met protein kinases Swaroop K. Vakkalanka, Dhanapalan Nagarathnam, Meyyappan Muthuppalaniappan, Govindarajulu Babu, Prashant K. Bhavar 2017-11-14
9790224 Dual selective PI3 delta and gamma kinase inhibitors Swaroop K. Vakkalanka, Prashant K. Bhavar, Govindarajulu Babu 2017-10-17
9783533 Glutaminase inhibitors Prashant K. Bhavar, Swaroop K. Vakkalanka, Merikapudi Gayatri Swaroop, Govindarajulu Babu 2017-10-10
9777018 Compounds as modulators of GPR-119 Dhanapalan Nagarathnam, Swaroop K. Vakkalanka, Gayatri S. Merikapudi 2017-10-03
9775841 Compounds as modulators of protein kinases Dhanapalan Nagarathnam, Swaroop K. Vakkalanka, Meyyappan Muthuppalaniappan, Govindarajulu Babu, Prashant K. Bhavar 2017-10-03
9758514 Modulators of calcium release-activated calcium channel Meyyappan Muthuppalaniappan, Gayatri S. Merikapudi, Swaroop K. Vakkalanka 2017-09-12
9758474 Immunomodulator and anti-inflammatory compounds Meyyappan Muthuppalaniappan, Prashant K. Bhavar, Swaroop K. Vakkalanka, Gayatri S. Merikapudi 2017-09-12
9737521 Pharmaceutical compositions containing a PDE4 inhibitor and a PI3 delta or dual PI3 delta-gamma kinase inhibitor Swaroop K. Vakkalanka 2017-08-22